CompoundIQ

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

OtherIntermediateLow Risk

Oxiracetam

Also known as: Neuromet

Oxiracetam is a water-soluble racetam considered more stimulating than piracetam, often used for logical thinking, focus, and memory tasks. It has been studied in Europe for cognitive impairment in elderly patients and dementia, with some positive findings for attention and concentration.

Evidence45/100 — Emerging

Risk Level

Low Risk

Difficulty

Intermediate
CAS Number62613-82-5
Molecular FormulaC6H10N2O3
ClassOther
CategoryNootropics

Mechanism of Action

Oxiracetam modulates AMPA and NMDA receptors and increases the release of excitatory neurotransmitters glutamate and acetylcholine, particularly in the hippocampus and cortex. It enhances long-term potentiation (LTP), a key mechanism for memory formation. It also increases phospholipid metabolism and protein kinase C activity in neuronal membranes.

Dosing Research

Typical dose: 800-2400 mg/day divided into 2-3 doses. Commonly taken as 800 mg two to three times daily. Water-soluble and can be taken without food. Half-life approximately 8 hours. Effects noticeable within 1-2 hours. A choline source is recommended as with all racetams.

Side Effects & Risks

Well-tolerated with a good safety profile. Headache (mitigated by choline), insomnia if taken late, nervousness or irritability in sensitive individuals. Mild stimulatory effect may not suit those prone to anxiety. No known serious adverse effects or dependency issues at standard doses.

Research Studies

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

Send Feedback

Help us improve CompoundIQ